Corbus Pharmaceuticals Stock (NASDAQ: CRBP) stock price, news, charts, stock research, profile.
Open | $43.520 |
Close | - |
Volume / Avg. | 112.050K / 286.789K |
Day Range | 43.510 - 46.000 |
52 Wk Range | 3.033 - 49.870 |
Market Cap | $472.779M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 7.21% |
Days to Cover | 2.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corbus Pharmaceuticals (NASDAQ: CRBP) through any online brokerage.
Other companies in Corbus Pharmaceuticals’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG) and Replimune Group (NASDAQ:REPL).
The latest price target for Corbus Pharmaceuticals (NASDAQ: CRBP) was reported by RBC Capital on Monday, May 13, 2024. The analyst firm set a price target for 77.00 expecting CRBP to rise to within 12 months (a possible 71.68% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $44.85 last updated Today at May 15, 2024 at 10:51 AM EDT.
There are no upcoming dividends for Corbus Pharmaceuticals.
Corbus Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Corbus Pharmaceuticals.
Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.